Clutch Rose Perkins Rose Twistlock Dorothy Perkins Dorothy Clutch Dorothy Twistlock xAI8Ip

Health System Access. Demystified.

 
New technologies can improve patient care and make the health system more efficient – but only if they reach the hands of medical professionals. MaRS EXCITE helps get them there.

We support companies whose innovative technologies could improve health outcomes, helping them navigate the complex process of gaining access to Ontario’s $50-billion health system.

Working in partnership with the Ministry of Health, the main funding entity in Ontario, EXCITE helps companies generate the contextual evidence they need to access the province’s market, including product value and other key stakeholder decision-making requirements.

The goal: Faster technology adoption. Better patient outcomes. More affordable health care.
 


Rose Twistlock Clutch Dorothy Twistlock Dorothy Perkins Clutch Perkins Rose Dorothy

Our Services

END-TO-END EXCITE

A comprehensive service that supports health technology companies through the entire process of accessing Ontario’s market. End-to-End EXCITE consists of three phases: technology appraisal, evaluation design & evidence generation, and implementation navigation.

Advantages:

  • Identifies disruptive health technologies aligned to health system needs
  • Co-designs a streamlined clinical trial protocol containing both regulatory and reimbursement endpoints
  • Connects companies with world class methodology centres to generate contextual evidence of their technology’s efficacy and value
  • Identifies systemic barriers that hinder adoption and diffusion of technology
  • Provides the company and Ministry of Health with a comprehensive market access plan detailing barriers, opportunities and potential implementation pathways

 

EXCITE MODULAR

A flexible offering that allows companies to engage with EXCITE in a manner customized for their market access needs.

Advantages:

  • Determines alignment of new technology with health system priorities, and validates business viability for commercialization
  • Rose Rose Perkins Twistlock Perkins Twistlock Dorothy Dorothy Clutch Clutch Dorothy Identifies evidence endpoints relevant to the health system for inclusion in protocol design
  • Rose Dorothy Perkins Rose Twistlock Clutch Dorothy Clutch Dorothy Twistlock Perkins Engages key system stakeholders, including the Ministry of Health, to explore opportunities to incorporate the technology in Ontario’s health system and identify any systemic barriers that could slow down adoption and uptake
  • Provides the company and Ministry of Health with a comprehensive market access plan detailing barriers, opportunities and potential implementation pathways

Clutch Perkins Rose Dorothy Clutch Twistlock Twistlock Dorothy Rose Dorothy Perkins  

Watch our video

 

Perkins Twistlock Dorothy Clutch Dorothy Twistlock Dorothy Rose Clutch Rose Perkins

 

SIGN UP FOR OUR NEWSLETTER